- Personal FinanceCompare Online BrokersTop StocksAlternative Investing
- CryptoGet StartedNFTs
Tools
Calendars
Short Interest
$22.64
0.53[2.40%]
At close: Jun 30
$22.11
-0.5300[-2.34%]
After Hours: 4:08PM EDT
15 minutes delayed
Day High/Low21.64 - 22.73
52 Week High/Low13.47 - 33.09
Open / Close22.03 / 22.64
Float / Outstanding43.4M / 43.6M
Vol / Avg.281K / 355.5K
Mkt Cap986M
P/E-
50d Avg. Price19.43
Div / Yield-
Payout Ratio-
EPS-0.43
Total Float43.4M
Merus (NASDAQ:MRUS), Quotes and News Summary
Merus (NASDAQ: MRUS)
Day High/Low21.64 - 22.73
52 Week High/Low13.47 - 33.09
Open / Close22.03 / 22.64
Float / Outstanding43.4M / 43.6M
Vol / Avg.281K / 355.5K
Mkt Cap986M
P/E-
50d Avg. Price19.43
Div / Yield-
Payout Ratio-
EPS-0.43
Total Float43.4M
Benzinga - Jun 6, 2022, 2:54PM
Benzinga - Jun 5, 2022, 11:02AM
Benzinga - May 19, 2022, 9:38AM
Benzinga - May 9, 2022, 5:14PM
Benzinga - Feb 28, 2022, 5:12PM
Benzinga - Feb 11, 2022, 4:48AM
Benzinga - Feb 10, 2022, 5:37AM
Benzinga - Jan 26, 2022, 7:07AM
Merus Appoints Shannon Campbell As Chief Commercial Officer And Regains Worldwide Rights To MCLA-145
Benzinga - Jan 25, 2022, 4:32PM
Benzinga - Dec 10, 2021, 12:36PM
Benzinga - Dec 10, 2021, 8:04AM
Benzinga - Dec 6, 2021, 6:44AM
Benzinga - Dec 2, 2021, 8:09AM
Benzinga - Nov 12, 2021, 6:12AM
Benzinga - Nov 4, 2021, 5:28PM
Benzinga - Nov 4, 2021, 5:28PM
Benzinga - Nov 3, 2021, 8:46AM
Benzinga - Nov 2, 2021, 4:40PM
Benzinga - Oct 8, 2021, 4:39AM
Benzinga - Oct 7, 2021, 11:40AM
Benzinga - Oct 7, 2021, 10:47AM
load more
Merus NV is a clinical-stage immuno-oncology company. It develops bispecific antibody therapeutics. The company is developing innovative full-length human bispecific antibody therapeutics, referred to as Biclonics. Merus only reportable segment comprising the discovery and development of innovative bispecific therapeutics. Some of its products in the pipeline include MCLA-128; MCLA-117; MCLA-158 and others.
Earnings
see more| Q2 2022 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED)2022-08-04 | ||||||
| REV | |||||||
| Q1 2022 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -0.620 | -0.430 | 0.1900 | ||||
| REV | 9.370M | 11.655M | 2.285M |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|
Merus Questions & Answers
Q
How do I buy Merus (MRUS) stock?
A
You can purchase shares of Merus (NASDAQ: MRUS) through any online brokerage.
Q
Who are Merus's (MRUS) competitors?
A
There are no as such competitors for Merus.
Q
What is the target price for Merus (MRUS) stock?
A
The latest price target for Merus (NASDAQ: MRUS) was reported by Citigroup on Thursday, May 19, 2022. The analyst firm set a price target for 37.00 expecting MRUS to rise to within 12 months (a possible 63.43% upside). 6 analyst firms have reported ratings in the last year.
Q
Current Stock Price for Merus (MRUS)?
A
The stock price for Merus (NASDAQ: MRUS) is $22.64 last updated Today at June 30, 2022, 8:00 PM UTC.
Q
Does Merus (MRUS) pay a dividend?
A
There are no upcoming dividends for Merus.
Q
When is Merus (NASDAQ:MRUS) reporting earnings?
A
Merus’s Q2 earnings are confirmed for Thursday, August 4, 2022.
Q
Is Merus (MRUS) going to split?
A
There is no upcoming split for Merus.
Q
What sector and industry does Merus (MRUS) operate in?
A
Merus is in the Healthcare sector and Biotechnology industry. They are listed on the NASDAQ.